Sinopharm Group Co's market cap is currently $7.38B. The company's EPS TTM is $0.089891917; its P/E ratio is 7.77; and it has a dividend yield of 4.01%. Sinopharm Group Co is scheduled to report earnings on August 22, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
